Annual report

Period2025-04-01 → 2026-03-31
Filed2026-06-18
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥2.6bn2025-04-01 → 2026-03-31Cons.Net sales
Revenue¥2.5bn2024-04-01 → 2025-03-31Cons.Net sales
Revenue¥2.6bn2023-04-01 → 2024-03-31vCons.Net sales (5-year summary)
Revenue¥2.4bn2022-04-01 → 2023-03-31vCons.Net sales (5-year summary)
Revenue¥2.4bn2021-04-01 → 2022-03-31vCons.Net sales (5-year summary)
Operating income¥357m2025-04-01 → 2026-03-31Cons.Operating income
Operating income¥336m2024-04-01 → 2025-03-31Cons.Operating income
Ordinary income¥396m2025-04-01 → 2026-03-31Cons.Ordinary income
Ordinary income¥354m2024-04-01 → 2025-03-31Cons.Ordinary income
Ordinary income¥387m2023-04-01 → 2024-03-31vCons.Ordinary income loss (5-year summary)
Ordinary income¥333m2022-04-01 → 2023-03-31vCons.Ordinary income loss (5-year summary)
Ordinary income¥352m2021-04-01 → 2022-03-31vCons.Ordinary income loss (5-year summary)
Profit before tax¥396m2025-04-01 → 2026-03-31Cons.Income before income taxes
Profit before tax¥340m2024-04-01 → 2025-03-31Cons.Income before income taxes
Net income (owners)¥286m2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥356m2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥327m2023-04-01 → 2024-03-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥243m2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥340m2021-04-01 → 2022-03-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥286m2025-04-01 → 2026-03-31Cons.Profit loss
Net income¥356m2024-04-01 → 2025-03-31Cons.Profit loss
Total assets¥5.0bnat 2026-03-31Cons.Assets
Total assets¥5.0bnat 2025-03-31Cons.Assets
Total assets¥5.2bnat 2024-03-31vCons.Total assets (5-year summary)
Total assets¥4.5bnat 2023-03-31vCons.Total assets (5-year summary)
Total assets¥4.6bnat 2022-03-31vCons.Total assets (5-year summary)
Total liabilities¥1.0bnat 2026-03-31Cons.Liabilities
Total liabilities¥1.2bnat 2025-03-31Cons.Liabilities
Net assets / equity¥4.0bnat 2026-03-31Cons.Net assets
Net assets / equity¥3.9bnat 2025-03-31Cons.Net assets
Net assets / equity¥3.7bnat 2024-03-31vCons.Net assets
Net assets / equity¥3.4bnat 2023-03-31vCons.Net assets (5-year summary)
Net assets / equity¥3.3bnat 2022-03-31vCons.Net assets (5-year summary)
Cash and deposits¥2.2bnat 2026-03-31Cons.Cash and deposits
Cash and deposits¥2.0bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥1.7bnat 2026-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2024-03-31vCons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31vCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥2.2bnat 2022-03-31vCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥583m2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥153m2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥399m2023-04-01 → 2024-03-31vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥105m2022-04-01 → 2023-03-31vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥659m2021-04-01 → 2022-03-31vCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥598m2025-04-01 → 2026-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥375m2024-04-01 → 2025-03-31Cons.Net cash provided by used in investment activities
Investing cash flow¥89m2023-04-01 → 2024-03-31vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥24m2022-04-01 → 2023-03-31vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥66m2021-04-01 → 2022-03-31vCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥154m2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥159m2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥146m2023-04-01 → 2024-03-31vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥226m2022-04-01 → 2023-03-31vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥72m2021-04-01 → 2022-03-31vCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥208.92025-04-01 → 2026-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥260.192024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥238.992023-04-01 → 2024-03-31vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥177.532022-04-01 → 2023-03-31vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥248.752021-04-01 → 2022-03-31vCons.Basic earnings loss per share (5-year summary)
Net assets per share¥2,930.63at 2026-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥2,823.85at 2025-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥2,685.76at 2024-03-31vCons.Net assets per share (5-year summary)
Net assets per share¥2,497.84at 2023-03-31vCons.Net assets per share (5-year summary)
Net assets per share¥2,392.34at 2022-03-31vCons.Net assets per share (5-year summary)
Equity ratio79.9%at 2026-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.8%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.9%at 2024-03-31vCons.Equity to asset ratio (5-year summary)
Equity ratio75.6%at 2023-03-31vCons.Equity to asset ratio (5-year summary)
Equity ratio70.4%at 2022-03-31vCons.Equity to asset ratio (5-year summary)
ROE7.3%2025-04-01 → 2026-03-31Cons.Rate of return on equity (5-year summary)
ROE9.4%2024-04-01 → 2025-03-31Cons.Rate of return on equity (5-year summary)
ROE9.2%2023-04-01 → 2024-03-31vCons.Rate of return on equity (5-year summary)
ROE7.3%2022-04-01 → 2023-03-31vCons.Rate of return on equity (5-year summary)
ROE10.9%2021-04-01 → 2022-03-31vCons.Rate of return on equity (5-year summary)
Employees123at 2026-03-31Cons.Number of employees
Employees124at 2025-03-31Cons.Number of employees
Employees128at 2024-03-31vCons.Number of employees
Employees134at 2023-03-31vCons.Number of employees
Employees134at 2022-03-31vCons.Number of employees
Revenue¥2.5bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥2.5bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥2.6bn2023-04-01 → 2024-03-31vStandaloneNet sales (5-year summary)
Revenue¥2.4bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥2.4bn2021-04-01 → 2022-03-31vStandaloneNet sales (5-year summary)
Operating income¥347m2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥342m2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥383m2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥357m2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥377m2023-04-01 → 2024-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥328m2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥342m2021-04-01 → 2022-03-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥383m2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥343m2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥276m2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥360m2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥319m2023-04-01 → 2024-03-31vStandaloneNet income loss (5-year summary)
Net income¥241m2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥331m2021-04-01 → 2022-03-31vStandaloneNet income loss (5-year summary)
Total assets¥5.0bnat 2026-03-31StandaloneAssets
Total assets¥5.0bnat 2025-03-31StandaloneAssets
Total assets¥5.1bnat 2024-03-31vStandaloneTotal assets (5-year summary)
Total assets¥4.5bnat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥4.6bnat 2022-03-31vStandaloneTotal assets (5-year summary)
Total liabilities¥997mat 2026-03-31StandaloneLiabilities
Total liabilities¥1.1bnat 2025-03-31StandaloneLiabilities
Net assets / equity¥4.0bnat 2026-03-31StandaloneNet assets
Net assets / equity¥3.8bnat 2025-03-31StandaloneNet assets
Net assets / equity¥3.6bnat 2024-03-31vStandaloneNet assets
Net assets / equity¥3.4bnat 2023-03-31vStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2022-03-31vStandaloneNet assets (5-year summary)
Cash and deposits¥2.1bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥1.9bnat 2025-03-31StandaloneCash and deposits
EPS (basic)¥201.872025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥263.082024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥232.872023-04-01 → 2024-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥175.862022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥241.582021-04-01 → 2022-03-31vStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥852025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1102024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1102023-04-01 → 2024-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥702022-04-01 → 2023-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥852021-04-01 → 2022-03-31vStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,895.44at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,800.73at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,658.93at 2024-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,484.83at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,385.25at 2022-03-31vStandaloneNet assets per share (5-year summary)
Equity ratio79.9%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.0%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio70.8%at 2024-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio75.8%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.4%at 2022-03-31vStandaloneEquity to asset ratio (5-year summary)
ROE7.1%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE9.6%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE9.1%2023-04-01 → 2024-03-31vStandaloneRate of return on equity (5-year summary)
ROE7.2%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE10.6%2021-04-01 → 2022-03-31vStandaloneRate of return on equity (5-year summary)
Shares issued1,393,459at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,393,459at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,393,459at 2024-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,393,459at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,393,459at 2022-03-31vStandaloneTotal number of issued shares (5-year summary)
Employees122at 2026-03-31StandaloneNumber of employees
Employees123at 2025-03-31StandaloneNumber of employees
Employees127at 2024-03-31vStandaloneNumber of employees
Employees133at 2023-03-31vStandaloneNumber of employees
Employees133at 2022-03-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 50
SegmentItemPeriodValue
Healthcare Related Productsreportable segmentcapex2025-04-01 → 2026-03-31¥4m
Healthcare Related Productsreportable segmentdepreciation2025-04-01 → 2026-03-31¥8m
Healthcare Related Productsreportable segmentrevenue2025-04-01 → 2026-03-31¥627m
Healthcare Related Productsreportable segmentrevenue external2025-04-01 → 2026-03-31¥627m
Healthcare Related Productsreportable segmentsegment assetsat 2026-03-31¥461m
Healthcare Related Productsreportable segmentsegment profit2025-04-01 → 2026-03-31−¥18m
Optical Applications And Special Customized Productsreportable segmentcapex2025-04-01 → 2026-03-31¥21m
Optical Applications And Special Customized Productsreportable segmentdepreciation2025-04-01 → 2026-03-31¥44m
Optical Applications And Special Customized Productsreportable segmentrevenue2025-04-01 → 2026-03-31¥1.0bn
Optical Applications And Special Customized Productsreportable segmentrevenue external2025-04-01 → 2026-03-31¥1.0bn
Optical Applications And Special Customized Productsreportable segmentsegment assetsat 2026-03-31¥950m
Optical Applications And Special Customized Productsreportable segmentsegment profit2025-04-01 → 2026-03-31¥329m
X Ray Residual Stress Analyzerreportable segmentcapex2025-04-01 → 2026-03-31¥43m
X Ray Residual Stress Analyzerreportable segmentdepreciation2025-04-01 → 2026-03-31¥20m
X Ray Residual Stress Analyzerreportable segmentrevenue2025-04-01 → 2026-03-31¥893m
X Ray Residual Stress Analyzerreportable segmentrevenue external2025-04-01 → 2026-03-31¥893m
X Ray Residual Stress Analyzerreportable segmentsegment assetsat 2026-03-31¥366m
X Ray Residual Stress Analyzerreportable segmentsegment profit2025-04-01 → 2026-03-31¥347m
—segment totalemployeesat 2026-03-31107 pure
Total Of Reportable Segments And Otherssegment totalcapex2025-04-01 → 2026-03-31¥68m
Total Of Reportable Segments And Otherssegment totaldepreciation2025-04-01 → 2026-03-31¥72m
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2026-03-31¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2026-03-31¥2.6bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2026-03-31¥1.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2026-03-31¥658m
Healthcare Related Productsreportable segmentcapex2024-04-01 → 2025-03-31¥2m
Healthcare Related Productsreportable segmentdepreciation2024-04-01 → 2025-03-31¥7m
Healthcare Related Productsreportable segmentrevenue2024-04-01 → 2025-03-31¥711m
Healthcare Related Productsreportable segmentrevenue external2024-04-01 → 2025-03-31¥711m
Healthcare Related Productsreportable segmentsegment assetsat 2025-03-31¥427m
Healthcare Related Productsreportable segmentsegment profit2024-04-01 → 2025-03-31¥40m
Optical Applications And Special Customized Productsreportable segmentcapex2024-04-01 → 2025-03-31¥487m
Optical Applications And Special Customized Productsreportable segmentdepreciation2024-04-01 → 2025-03-31¥23m
Optical Applications And Special Customized Productsreportable segmentrevenue2024-04-01 → 2025-03-31¥936m
Optical Applications And Special Customized Productsreportable segmentrevenue external2024-04-01 → 2025-03-31¥936m
Optical Applications And Special Customized Productsreportable segmentsegment assetsat 2025-03-31¥1.1bn
Optical Applications And Special Customized Productsreportable segmentsegment profit2024-04-01 → 2025-03-31¥259m
X Ray Residual Stress Analyzerreportable segmentcapex2024-04-01 → 2025-03-31¥28m
X Ray Residual Stress Analyzerreportable segmentdepreciation2024-04-01 → 2025-03-31¥10m
X Ray Residual Stress Analyzerreportable segmentrevenue2024-04-01 → 2025-03-31¥839m
X Ray Residual Stress Analyzerreportable segmentrevenue external2024-04-01 → 2025-03-31¥839m
X Ray Residual Stress Analyzerreportable segmentsegment assetsat 2025-03-31¥415m
X Ray Residual Stress Analyzerreportable segmentsegment profit2024-04-01 → 2025-03-31¥363m
Total Of Reportable Segments And Otherssegment totalcapex2024-04-01 → 2025-03-31¥518m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-04-01 → 2025-03-31¥40m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2025-03-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2025-03-31¥2.5bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2025-03-31¥1.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2025-03-31¥662m
—segment totalemployeesat 2026-03-31106 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,223
ItemContextValueUnit
Percentage of shareholdings other corporationsCurrentYearInstant_OrdinaryShareMember0.0847
Percentage of shareholdings foreigners other than individualsCurrentYearInstant_OrdinaryShareMember0.0180
Percentage of shareholdings foreign individualsCurrentYearInstant_OrdinaryShareMember0.0004
Percentage of shareholdings individuals and othersCurrentYearInstant_OrdinaryShareMember0.8676
Number of shares heldCurrentYearInstant_No1MajorShareholdersMember126700
Shareholding ratioCurrentYearInstant_No1MajorShareholdersMember0.0926
Number of shares heldCurrentYearInstant_No2MajorShareholdersMember115073
Shareholding ratioCurrentYearInstant_No2MajorShareholdersMember0.0841
Number of shares heldCurrentYearInstant_No3MajorShareholdersMember37000
Shareholding ratioCurrentYearInstant_No3MajorShareholdersMember0.0270
Number of shares heldCurrentYearInstant_No4MajorShareholdersMember36940
Shareholding ratioCurrentYearInstant_No4MajorShareholdersMember0.0270
Number of shares heldCurrentYearInstant_No5MajorShareholdersMember36100
Shareholding ratioCurrentYearInstant_No5MajorShareholdersMember0.0264
Number of shares heldCurrentYearInstant_No6MajorShareholdersMember34400
Shareholding ratioCurrentYearInstant_No6MajorShareholdersMember0.0251
Number of shares heldCurrentYearInstant_No7MajorShareholdersMember33500
Shareholding ratioCurrentYearInstant_No7MajorShareholdersMember0.0245
Number of shares heldCurrentYearInstant_No8MajorShareholdersMember30600
Shareholding ratioCurrentYearInstant_No8MajorShareholdersMember0.0224
Number of shares heldCurrentYearInstant_No9MajorShareholdersMember25000
Shareholding ratioCurrentYearInstant_No9MajorShareholdersMember0.0183
Number of shares heldCurrentYearInstant_No10MajorShareholdersMember22900
Shareholding ratioCurrentYearInstant_No10MajorShareholdersMember0.0167
Number of shares heldCurrentYearInstant498213
Shareholding ratioCurrentYearInstant0.3642
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember25300
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1354400
Number of voting rights issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember13544
Number of shares issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember13759
Number of shares issued shares voting rightsCurrentYearInstant1393459
Number of voting rights issued shares voting rightsCurrentYearInstant13544
Number of shares held in own name treasury shares etcCurrentYearInstant_Row1Member25300
Number of shares held in others names treasury shares etcCurrentYearInstant_Row1Member-
Total number of shares held treasury shares etcCurrentYearInstant_Row1Member25300
Shareholding ratio treasury shares etcCurrentYearInstant_Row1Member0.0182
Number of shares held in own name treasury shares etcCurrentYearInstant25300
Number of shares held in others names treasury shares etcCurrentYearInstant-
Total number of shares held treasury shares etcCurrentYearInstant25300
Shareholding ratio treasury shares etcCurrentYearInstant0.0182
Total amount of dividends dividends of surplusFilingDateInstant_Row1Member116285000JPY
Dividend per share dividends of surplusFilingDateInstant_Row1Member85.00
Number of male directors and other officersFilingDateInstant6
Number of female directors and other officersFilingDateInstant1
Ratio of female directors and other officersFilingDateInstant0.143
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E02021-000AonoYoshiyukiMember19700

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2026-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass rounding
balance sheet identitynon_consolidated 2026-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2026-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass